GXEA:FRA
Lakefront Biotherapeutics NV - ADR
€26.40
0.00%
(0.00) 1D
Oct 13, 8:03:08 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXEA...
Open
€26.40
High
€26.40
Low
€26.40
Mkt. cap
1.73B
Avg. vol.
17.00
Volume
0.00
52-wk high
€29.40
52-wk low
€22.40
No. of employees
196
Open
€26.40
High
€26.40
Low
€26.40
Mkt. cap
1.73B
Avg. vol.
17.00
Volume
0.00
52-wk high
€29.40
52-wk low
€22.40
No. of employees
196
News stories
From web sources and news partners
Robotics & Automation News
·
11 minutes ago
PlusAI moves closer to Nasdaq listing as it targets 2027 autonomous truck launch
Benzinga
·
1 hour ago
VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at Worl
The Lufkin Daily News
·
1 hour ago
Wall St subdued in choppy trade after big bank earnings, chips slide
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV - ADR
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com